OBJECTIVE To review the evidence and provide recommendations on screening for and management of vulvovaginal candidiasis, trichomoniasis, and bacterial vaginosis. OUTCOMES OUTCOMES evaluated include the efficacy of antibiotic treatment, cure rates for simple and complicated infections, and the implications of these conditions in pregnancy. EVIDENCE Published literature was retrieved through...

Trichomonas gallinae isolates from pigeon and chicken were amplified by polymerase chain reaction using Fe hydrogenase gene characterized molecular tools to determine the geographical location sequences analyzed phylogenetically. The in present study 100% similar T. of Iran Austria. Random samples found positive for trichomoniasis culture throat swab live birds confirmed PCR. showed clear band ...

Analysis of eight groups of data collected at varying intervals during a period of seven years showed fluctuations in the sensitivity of tests to diagnose trichomoniasis in women. The best results were obtained from fresh, correctly prepared Diamond's medium, Feinberg-Whittington's medium, and modified Squires and McFadzean's medium (which showed 82% to 94% relative sensitivity). Poor results w...

Trichomonas vaginalis was originally considered a commensal organism until the 1950s when the understanding of its role as a sexually transmitted infection (STI) began to evolve. Trichomoniasis has been associated with vaginitis, cervicitis, urethritis, pelvic inflammatory disease (PID), and adverse birth outcomes. Infection with T vaginalis could have an important role in transmission and acqu...

background: trichomoniasis is a worldwide sexually transmitted disease (std), and is associated with important public health problems, including enhancement of hiv transmission. the prevalence of the parasite, trichomonas vaginalis, depends on host factors such as age, sexual activity, number of sexual partners and sexual behavior. the aim of the study was to evaluate the prevalence of trichomo...

Since there is abundant experience of the clinical use of metronidazole, it is appropriate to begin a consideration of its toxicology by reviewing reports of side-effects in man. Until a few years ago the use of metronidazole in clinical medicine was more or less confined to the treatment of patients with trichomoniasis. For this purpose the oral administration of 200 mg three times per day for...

The in vitro activities of tinidazole and metronidazole against Trichomonas vaginalis isolates clinically resistant to metronidazole were compared. Minimal lethal concentrations (MLCs) of tinidazole were significantly lower than MLCs of metronidazole. Increased metronidazole resistance correlated with increased tinidazole resistance. These data support a role for tinidazole in the treatment of ...